Doctor Thomas Robey sits in a courtyard at Providence Regional Medical Center on Thursday, in Everett. (Ryan Berry / The Herald)

Doctor Thomas Robey sits in a courtyard at Providence Regional Medical Center on Thursday, in Everett. (Ryan Berry / The Herald)

‘It’d be a miracle’: Providence tests new treatment for meth addiction

Monoclonal antibodies could lead to the first drug designed to fight meth addiction. Everett was chosen due to its high meth use.

EVERETT — Samuel Hirst’s detox center treats patients addicted to opioids. But the vast majority are also hooked on meth.

Hirst can rely on meds specifically formulated to help folks stay off fentanyl, heroin or oxycodone. As for meth?

“There’s no real standard treatment,” Hirst said.

In recent years, meth has consistently driven more than a third of Snohomish County’s overdose deaths. There’s no FDA-approved drug, though, designed to treat meth addiction.

A doctor down the road from Hirst wants to change that.

Providence’s Dr. Thomas Robey is enrolling emergency department patients in a trial-run for new monoclonal antibodies. Just four emergency departments nationwide are testing the new injectable treatment — one Robey said could be a game-changer for locals hooked on meth.

Monoclonal antibodies gained attention this year as a treatment for COVID-19. The molecules are also used for cancer patients, as they target unwanted cells or toxins in the body.

“It’s like an antidote,” Robey told The Daily Herald. “It’s a similar technology to what we use to treat snake bites.”

The drug binds tight to amphetamines in the bloodstream, pulling them away from the central nervous system and allowing the body to excrete them.

Normally, when patients come into the ER in a meth-induced psychosis, Robey’s team can administer sedatives and simply wait for agitation, paranoia and hallucinations to wear off. That can take hours. After that, some doctors prescribe antianxiety medications or antidepressants to help patients try to stay off the drug.

These monoclonal antibodies work differently. Within 30 minutes, enough meth can be removed from the brain that patients are no longer high.

“And that’s really phenomenal,” Robey said. “Because a lot of dangerous activity that individuals engage in when they’re high on meth has to do with paranoia and agitation.”

The “real kicker,” as Robey puts it, is how long-acting the drug is. With a half-life of 19 days, it can act in the body for more than a month. That means patients are blocked from getting high — or as high as they normally would — if they relapse during that time. That month or so could be enough time to help his patients, who are often unhoused, to get an ID, stable housing or other necessary healthcare.

The trial is small. Only 40 patients will be enrolled nationwide. So far, about 10 have been enrolled at Providence. Robey said the results have already been promising. Only one patient has failed to follow up with doctors after receiving the drug.

“I think part of it has to do with the fact that they’re able to get their lives together,” Robey said. “We have so many people in the study who’ve been chronically unhoused who have housing by the time they get to their 30-day followup. It’s unbelievable.”

The long-acting monoclonal antibodies sound promising to Hirst.

“Meth is so difficult for people to put down. Especially with the amount that’s out there right now,” he said. “It’d be a miracle if there’s some way to … keep them sober at least for a couple weeks.”

The research is slow-going, though.

Dr. W. Brooks Gentry is overseeing the national trial. From his office in Little Rock, Arkansas, he recalled the first grant he received to look into this meth treatment. That was back in the 1990s. About $65 million has been poured into the research, but it has come in small, piecemeal grants from the National Institute of Drug Abuse.

“It’s not viewed by entrepreneurial types as something that could be a big money-maker. So they don’t invest,” he said. Plus, “there’s still a bias, I believe, that this is a social ill and not a medical problem.”

Back in the ’90s, Gentry’s colleague was developing monoclonal antibodies targeting PCP, a drug known as “angel dust.”

“What we realized at that point was that Arkansas was No. 1 in the country for the number of methamphetamine labs per capita,” Gentry said. “This was still at the time when local production was a thing.”

So the team shifted their focus to meth. Since then, the meth on the streets has changed. Over the decades, supply has increased, prices dropped and the chemical makeup of the drug has gotten stronger and more dangerous.

When the antibodies were finally ready for human trials, Gentry’s team wanted to use ERs in places with high concentrations of meth use. They used heat maps to figure out where the drug was most prevalent.

“Y’all were unfortunately toward the top of the list,” Gentry said. “It’s heartbreaking for your community that you have such a problem.”

Even so, Robey said he’s thrilled his emergency department is part of the process.

“Even though we’re the safety net,” he said, “patients who are addicted to drugs still often fall through that.”

According to Gentry, federal approval of the drug could take five to six years, if everything goes to plan. He hopes the prospect of a new treatment can give hope to those hooked on meth.

“They tend to give up. Because there’s nothing (to treat meth addiction), so why would I even try?” Gentry said. “And that’s discouraging to hear. If we could give them some hope, that would be a big deal.”

Claudia Yaw: 425-339-3449; claudia.yaw@heraldnet.com; Twitter: @yawclaudia.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Local News

Customers enter and exit the Costco on Dec. 2, 2022, in Lake Stevens. (Olivia Vanni / The Herald)
Costco stores could be impacted by looming truck driver strike threat

Truck drivers who deliver groceries and produce to Costco warehouses… Continue reading

Two Washington State ferries pass along the route between Mukilteo and Clinton as scuba divers swim near the shore Sunday, Oct. 22, 2023, in Mukilteo, Washington. (Ryan Berry / The Herald)
Ferry system increases ridership by a half million in 2024

Edmonds-Kingston route remains second-busiest route in the system.

Alina Langbehn, 6, center, and Vera A., 6, right, sit on a swing together at Drew Nielsen Neighborhood Park after school on Tuesday, Jan. 28, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Everett council votes to renovate Drew Nielsen Park

Construction on the $345,000 upgrade could start as early as this fall.

Northshore School District bus driver Stewart O’Leary pictured next to his buses shattered drivers side windshield on Friday, Feb. 14, 2025 in Bothell, Washington. (Olivia Vanni / The Herald)
‘Put me in, coach’: Bus driver back at work after struck by metal bar

Stewart O’Leary, a Northshore employee, has received national attention for his composure during a frightening bus trip.

Lynnwood councilor Joshua Binda speaks during a Lynnwood City Council meeting on Wednesday, Nov. 20, 2024. (Olivia Vanni / The Herald)
Does the Lynnwood Council VP live in Lynnwood? It’s hard to say.

Josh Binda’s residency has been called into question following an eviction and FEC filings listing an Everett address. He insists he lives in Lynnwood.

Robin Cain with 50 of her marathon medals hanging on a display board she made with her father on Thursday, Jan. 2, 2025 in Lake Stevens, Washington. (Olivia Vanni / The Herald)
Running a marathon is hard. She ran one in every state.

Robin Cain, of Lake Stevens, is one of only a few thousand people to ever achieve the feat.

People line up to grab food at the Everett Recovery Cafe on Wednesday, Dec. 4, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Coffee, meals and compassion are free at the Everett Recovery Cafe

The free, membership-based day center offers free coffee and meals and more importantly, camaraderie and recovery support.

The Everett Wastewater Treatment Plant along the Snohomish River on Thursday, June 16, 2022 in Everett, Washington. (Olivia Vanni / The Herald)
Everett water, sewer rates could jump 43% by 2028

The rate hikes would pay for improvements to the city’s sewer infrastructure.

The bond funded new track and field at Northshore Middle School on Thursday, Oct. 24, 2024 in Bothell, Washington. (Courtesy of Northshore School District)
Northshore School District bond improvements underway

The $425 million bond is funding new track and field complexes, playgrounds and phase one of two school replacements.

An American Robin picks a berry from a holly tree on Thursday, Feb. 13, 2025 in Edmonds, Washington. (Olivia Vanni / The Herald)
Calling all birders for the annual Great Backyard Bird Count

The Audubon Society will hold its 28th annual Great Backyard… Continue reading

A view of one of the potential locations of the new Aquasox stadium on Monday, Feb. 26, 2024 in Everett, Washington. The site sits between Hewitt Avenue, Broadway, Pacific Avenue and the railroad. (Olivia Vanni / The Herald)
Initial prep work for AquaSox stadium to start, with $200k price tag

The temporary agreement allows some surveying and design work as the city negotiates contracts with designers and builders.

Aaron Kennedy / The Herald
The Joann Fabric and Crafts store at 7601 Evergreen Way, Everett, is one of three stores in Snohomish County that will close as part of the retailer’s larger plan to shutter more than half of its stores nationwide.
Joann store closure plan includes Everett, Arlington, Lynnwood locations

The retail giant filed a motion in court to close approximately 500 stores in the U.S.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.